Skip to content
Close
CONTACT US
CONTACT US
Expertise
Technology
Ultratouch
Verify

Workflow-focused platform and complete prior authorization solution

Learn How →
Ultratouch
Engage

Enhance product access, automate patient outreach, and improve patient care

Learn How →
Ultratouch
Patient Management

Manage complicated patient-related accreditation requirements

Learn How →
ComplySuite

Built by pharmacists for pharmacy organizations, accreditation, licensing, and regulatory compliance management in one, configurable platform

Learn How →
Ready to Talk? Contact Us
See How D2 Can Partner With Your Healthcare Organization
office buildings

End-to-End Market Access Partner Services

in partnership with  us pharma consulting logo white

Single-vendor support maximizing portfolio company value through integrated healthcare technology & pharmaceutical consulting excellence - backed by over 15 years of expertise. 

Book A Consultation

More powerful than traditional consulting: One strategic partner leveraging integrated healthcare technology & pharmaceutical consulting excellence.

D2 Solutions, in partnership with U.S. Pharma Consulting, eliminates multi-vendor coordination gaps by providing an integrated advisory and patient service model. Our solution delivers comprehensive end-to-end value chain advisory, consulting, and operational management services combined with proven healthcare technology platforms. We transform portfolio companies into market-ready enterprises while protecting your investment thesis.

125+ successful product launches
400+ industry partners with 100% client satisfaction
35% average faster time-to-market
AdobeStock_251401373-1

Challenge: The High Cost of a Fragmented Approach

Many Healthcare Private Equity investments underperform. Traditional consulting approaches often create costly gaps and execution failures, delivering theoretical frameworks that fail in real-world operations. Key challenges include:

  • Unoptimized portfolio company performance.
  • Fragmented consulting that extends timelines and creates gaps.
  • Unaddressed regulatory and supply chain complexities.
  • Difficulties in understanding true market opportunity.
  • Rapidly changing dynamics in the market structure.
  • Lack of end-to-end value chain analysis and risk mitigation.
d2-a4e7-1669660441-1
pharmacy500_sq_red_4C_logo
k5k84Untitled-15

Solution: D2's Integrated Partnership

Comprehensive Advisory, Consulting & Management Platform

Unlike fragmented approaches, our integrated model eliminates costly delays and redundant fees by coordinating all commercial efforts with simultaneous technology deployment and regulatory preparation. We provide comprehensive, end-to-end advisory grounded in 15+ years of real-world expertise empowering over 400 healthcare leaders across Pharmaceutical, Biotech, Hospital, and Distributor organizations. This award-winning experience allows us to deliver operationally sound strategies that prevent the common failures of purely theoretical plans.

  • 30-40% faster time-to-market through integrated approach.
  • Reduced capital burn via single-source model, outsourced services, and process automation.
  • Enhanced valuations from market-ready companies with automated operations.
  • Risk mitigation through comprehensive expertise, preventing costly missteps.
AdobeStock_300777895-1

Business Case Study:
How Integrated Market Access Prevents Launch Failure

Summary
A company invested significant R&D and commercial launch expenses for an acute pain management product, only to achieve minimal revenue. The partnership was terminated due to "poor commercial performance" and leadership that "does not have leadership that understood how to successfully launch a product."

Commercial Impact
The failure resulted in a complete loss of market opportunity, declining market share, and the product's effective withdrawal from the US market.

How D2 Prevents Launch Failure
This substantial financial loss could have been prevented by engaging a single-source regulatory and commercial partner from day one to develop a comprehensive strategy, establish market access, and create sustainable distribution networks.

Digital-_Engage-Logo-Mark-07
Proven SaaS Solutions
Our proprietary platforms, ComplySuite®, UltraTouch®, and HubSuite™, automate essential compliance, patient engagement, and market access processes. These promote market-ready companies with scalable, automated operations that drive enhanced valuations.
Asset 26PM-icon-mark
Global Expertise
D2 offers global experience in product development and supply chain analysis to build robust, sustainable distribution networks. This prevents the critical execution failures and market access gaps that derail launches, ensuring your product reaches its intended market efficiently
Asset 21liscense-icon
Accelerated Commercialization & Regulatory Execution
Quicken market launch timelines and lower investment through expert consulting, outsourced services, and proven execution of FDA establishment, licensing, and commercial launch requirements.
Asset 11market-access-icon
Full-Service Support
With experience serving over 500 partners, including Pharmaceutical and Biotech manufacturers, Pharmacies, Payers, PBMs, HUBs, Distributors, and Hospital Systems, we solve complex challenges from initial pricing strategy to full commercial launch.

Business Case Study:
How Integrated Market Access Prevents Launch Failure.

Summary
A Manufacturer with a unique, first-in-class product invested over $100K with a Market Access Advisory Group to determine their go-to-market pricing and contracting strategy. The firm was advised that at a certain price point the product would be covered by all payers at a Tier 1 formulary position with low patient copays.

Commercial Impact
The advisory group failed to realize that as a Branded product, it could not achieve a Generic-only Tier 1 position. The manufacturer was forced into unplanned rebate contracting during the critical launch period, deflating their gross-to-net opportunity.

How D2 Prevents Launch Failure
The Manufacturer was forced to engage in rebate contracting in an effort to attain a Tier 2 (preferred brand) status. This forced contracting was not contemplated in the companies pricing strategy, costing the company precious time for contract negotiations and deflating their gross-to-net opportunity. Our integrated approach prevents these costly disconnects by combining operational technology with commercial and regulatory expertise from project inception.

AdobeStock_300777895

Where Pharmaceutical Wisdom Meets Precision Excellence

We welcome the opportunity to discuss how our experience can enhance your healthcare company and product portfolio assessment. Our initial assessment identifies immediate value creation opportunities while establishing the foundation for superior investment returns.
Book A Consultation
D2 Solutions Logo Color
us pharma consulting llc logo